Form 13-F position report

* DOLBY LABORATORIES INC

Reported by Clearbridge Investments LLC

Company profile Manager portfolio Source filing
DLB CUSIP 25659T107 Manager CIK 0001348883
Latest reported change

Reported 3,372,687 shares, down 64,116 (1.9%) from the prior quarter.

Reported value 6.2%; share count -1.9% vs. the prior quarter.

Reduced
% of reported 13F value 0.22% This manager · Q4 2021
Shares 3,372,687 Quarter-end amount reported
Reported value $321,147,000 Fair value at quarter end
Consecutive quarters held 35 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q1 2025 Reduced 0 -1,165,919 (-100.0%) 0 $0 2025-05-13
Q4 2024 Reduced 1,165,919 -510,611 (-30.5%) 0.07% $91,058,250 2025-02-12
Q3 2024 Reduced 1,676,530 -325,377 (-16.3%) 0.1% $128,304,844 2024-11-12
Q2 2024 Reduced 2,001,907 -336,397 (-14.4%) 0.13% $158,611,120 2024-08-14
Q1 2024 Reduced 2,338,304 -80,490 (-3.3%) 0.16% $195,879,714 2024-05-13
Q4 2023 Reduced 2,418,794 -111,841 (-4.4%) 0.18% $208,451,638 2024-02-09
Q3 2023 Reduced 2,530,635 -85,031 (-3.3%) 0.19% $200,578,114 2023-11-13
Q2 2023 Reduced 2,615,666 -202,377 (-7.2%) 0.2% $218,878,897 2023-08-11
Q1 2023 Reduced 2,818,043 -85,350 (-2.9%) 0.23% $240,717,240 2023-05-12
Q4 2022 Reduced 2,903,393 -210,060 (-6.7%) 0.2% $204,805,314 2023-02-10
Q3 2022 Reduced 3,113,453 -105,973 (-3.3%) 0.2% $202,841,000 2022-11-14
Q2 2022 Reduced 3,219,426 -99,188 (-3.0%) 0.21% $230,382,000 2022-08-11
Q1 2022 Reduced 3,318,614 -54,073 (-1.6%) 0.2% $259,582,000 2022-05-13
Q4 2021 Reduced 3,372,687 -64,116 (-1.9%) 0.22% $321,147,000 2022-02-11
Q3 2021 Reduced 3,436,803 -37,315 (-1.1%) 0.22% $302,439,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

413 managers reported * DOLBY LABORATORIES INC for Q4 2021.

Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,157,704 +7,488 0.01% $586,337,000 35 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Added 3,525,296 +257,199 1.14% $335,679,000 8 qtrs
BlackRock Inc Reduced 3,427,423 -297,258 < 0.01% $326,361,000 35 qtrs
Clearbridge Investments LLC This report Reduced 3,372,687 -64,116 0.22% $321,147,000 35 qtrs
Jackson Square Partners LLC Added 3,228,356 +497,125 2.58% $307,404,000 5 qtrs
SOMA EQUITY PARTNERS LP Unchanged 2,300,000 0 6.63% $219,006,000 6 qtrs
JANUS HENDERSON GROUP PLC Reduced 1,966,318 -144,325 0.08% $187,233,000 23 qtrs
Ninety One UK Ltd Added 1,686,493 +1,483,012 0.38% $160,588,000 2 qtrs
MACKENZIE FINANCIAL CORP Added 1,656,550 +219,914 0.21% $157,737,000 16 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 1,634,004 +325,763 0.03% $155,591,000 35 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 11, 2022
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
3,266,525
Shared
0
None
106,162

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.